Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Celgene (now Bristol Myers Squibb)
Princeton, New Jersey, United States
- Ownership
- Private
- Employees
- ~30000
- Development stage
- Other
01
Overview
The combined company has a diverse portfolio, including blockbuster drugs and advanced cell therapies. Post-acquisition, BMS reported eight products with over $1 billion in annual sales and multiple drugs in late-stage development (six expected to launch within two years post-merger). Juno’s CAR-T programs broadened BMS's cell therapy capabilities. Recent FDA approvals included fedratinib and luspatercept-aamt before the merger
- Therapeutic areas
- ImmunologyRheumatologyHematologyDermatologyCardiovascularOtherOncology
- Modalities
- Small moleculeMonoclonal antibodyCAR-T cell therapyCell therapyBiologicProtein therapy (fusion protein)
- Industry
- Pharma
02
Partnerships
Juno Therapeutics (acquired for cell therapy)multiple academic and biotech partnershipsbluebird bioAcceleron Pharma
Beyond the preview
Go deeper on Celgene (now Bristol Myers Squibb).
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Celgene (now Bristol Myers Squibb).